The following medical description of a pancreas is provided. This is a medical observation from a doctor. The doctor notes one or multiple cysts and their dimensions. From the potentially multiple size values, the doctor is looking for the largest dimension of any of the cyst observations which is called the dominant cyst size. 

    ***Examples: 
    Pancreas: 'There is again noted to be markedly atrophic with fatty replacement, similar to prior study. There is possibly a cystic lesion in the tail the pancreas that measures up to 2.2 cm and possibly, a second adjacent cystic lesion that measures approximately 1.4 cm. These appear similar to prior study. They possibly represent pseudocysts although other cystic lesions of the pancreas do not be excluded. It is also conceivable be simply represent fluid filled small bowel loops although it would be somewhat unusual for them to have the same appearance over multiple studies. 
    Dominant Cyst Size: 2.2 cm

    Pancreas: 'Numerous pancreatic cystic lesions are redemonstrated measuring up to 2.1 cm. These are nonspecific and may represent sequela of prior pancreatitis or sidebranch IPMNs. These can be reassessed with MRI in one year.'
    Dominant Cyst Size: 2.1cm

    Pancreas: 'Pancreas: Pancreas appear atrophic. Hypodense lesion seen in the uncinate process of the pancreas (series 6 images 519) measuring 1.6 x 2.3 cm previously measuring 2.4 x 1.0 cm. Another well-defined cystic attenuation lesion seen in the body of the pancreas extending inferiorly measuring 1.6 x 2.1 cm and tail of the pancreas measuring 1.2 x 1.6 cm not well appreciated on prior scan due to movement artifact measuring approximately 1.5 cm on 9/7/2021.'

    Dominant Cyst Size: 2.4 cm

    Pancreas: 'Pancreas: A 3 cm x 2.7 cm pancreatic tail cystic lesion has increased in size from prior (previously 2.4 cm x 1.9 cm). An approximately 1 cm pancreatic neck cyst, now measures about 3.1 cm cyst associated centimeters previously along the maximum transverse dimension. Remainder of the pancreas is unchanged.'
    Dominant Cyst Size: 3.1 cm

    Pancreas: 'PANCREAS: Evaluation of the pancreatic cystic lesions is limited by CT technique. Although the largest lesion in the body of the pancreas is stable, measuring up to 14 mm. No pancreatic ductal dilatation. No findings of acute pancreatitis.'
    Dominant Cyst Size : 14 mm
    
    ***Input
    Pancreas: 
 
 
FINDINGS: A cystic focus is seen in the anterior aspect of the pancreatic neck. This is currently estimated at approximately 21 mm in AP diameter, unchanged from the most recent prior MRI. This has been previously measured at 16 mm on MRI 12/14/2012, 17 mm on CT 12/9/2011 and 12 mm on CT 9/14/2010. There are several minute foci of increased signal on T2-weighted sequences associated with the pancreatic head, 2 adjacent to one another seen on image 16 of T2 series #4 estimated at 2-3 mm in diameter and one along the anterior aspect of the pancreas on axial image 15 of series 4 estimated at 2 mm in diameter that have not been clearly appreciated on the prior studies. No other regions of abnormal signal or abnormal enhancement of the pancreas are appreciated. No pancreatic duct dilation is seen. The liver is normal in size and shape, without focal abnormalities appreciated. The gallbladder is not identified. Prior CT examinations revealed metallic clips in the gallbladder fossa, indicating prior cholecystectomy. The spleen is unremarkable. There is no evidence for adrenal enlargement. The kidneys reveal several minute cortical cysts bilaterally which are similar to the findings on previous exams. No significant renal abnormalities are appreciated. There is no evidence for retroperitoneal mass or pathologic adenopathy. No retroperitoneal vascular abnormality is seen. There is no fluid in the upper abdomen appreciated. No other significant findings are noted.
 MRI OF THE ABDOMEN PRE AND POSTCONTRAST
 
CLINICAL INFORMATION: History of IPMN.
 
COMPARISON MRI 11/2/2013, MRI 12/4/2012, CT 12/9/2011 and CT 9/14/2010.
 
FINDINGS: A cystic focus is seen in the anterior aspect of the pancreatic neck. This is currently estimated at approximately 21 mm in AP diameter, unchanged from the most recent prior MRI. This has been previously measured at 16 mm on MRI 12/14/2012, 17 mm on CT 12/9/2011 and 12 mm on CT 9/14/2010. There are several minute foci of increased signal on T2-weighted sequences associated with the pancreatic head, 2 adjacent to one another seen on image 16 of T2 series #4 estimated at 2-3 mm in diameter and one along the anterior aspect of the pancreas on axial image 15 of series 4 estimated at 2 mm in diameter that have not been clearly appreciated on the prior studies. No other regions of abnormal signal or abnormal enhancement of the pancreas are appreciated. No pancreatic duct dilation is seen. The liver is normal in size and shape, without focal abnormalities appreciated. The gallbladder is not identified. Prior CT examinations revealed metallic clips in the gallbladder fossa, indicating prior cholecystectomy. The spleen is unremarkable. There is no evidence for adrenal enlargement. The kidneys reveal several minute cortical cysts bilaterally which are similar to the findings on previous exams. No significant renal abnormalities are appreciated. There is no evidence for retroperitoneal mass or pathologic adenopathy. No retroperitoneal vascular abnormality is seen. There is no fluid in the upper abdomen appreciated. No other significant findings are noted.
 MRI OF THE ABDOMEN PRE AND POSTCONTRAST
 
CLINICAL INFORMATION: History of IPMN.
 
COMPARISON MRI 11/2/2013, MRI 12/4/2012, CT 12/9/2011 and CT 9/14/2010.
 
FINDINGS: A cystic focus is seen in the anterior aspect of the pancreatic neck. This is currently estimated at approximately 21 mm in AP diameter, unchanged from the most recent prior MRI. This has been previously measured at 16 mm on MRI 12/14/2012, 17 mm on CT 12/9/2011 and 12 mm on CT 9/14/2010. There are several minute foci of increased signal on T2-weighted sequences associated with the pancreatic head, 2 adjacent to one another seen on image 16 of T2 series #4 estimated at 2-3 mm in diameter and one along the anterior aspect of the pancreas on axial image 15 of series 4 estimated at 2 mm in diameter that have not been clearly appreciated on the prior studies. No other regions of abnormal signal or abnormal enhancement of the pancreas are appreciated. No pancreatic duct dilation is seen. The liver is normal in size and shape, without focal abnormalities appreciated. The gallbladder is not identified. Prior CT examinations revealed metallic clips in the gallbladder fossa, indicating prior cholecystectomy. The spleen is unremarkable. There is no evidence for adrenal enlargement. The kidneys reveal several minute cortical cysts bilaterally which are similar to the findings on previous exams. No significant renal abnormalities are appreciated. There is no evidence for retroperitoneal mass or pathologic adenopathy. No retroperitoneal vascular abnormality is seen. There is no fluid in the upper abdomen appreciated. No other significant findings are noted.
    Output: 
    